HEAL logo

iShares IV - iShares Healthcare Innovation UCITS ETF Share Price

Symbol: LSE:HEALMarket Cap: US$965.0mCategory: Diversified Financials

HEAL Share Price Performance

US$8.16
0.24 (3.06%)
US$8.16
0.24 (3.06%)
Price US$8.16

HEAL Community Narratives

There are no narratives available yet.

Recent HEAL News & Updates

iShares IV Public Limited Company - iShares Healthcare Innovation UCITS ETF Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

US$0

Other Expenses

US$0

Earnings

Last Reported Earnings
n/a
Next Reporting Earnings
n/a
Earnings per share (EPS)
0
Gross Margin
0%
Net Profit Margin
0%
Debt/Equity Ratio
0%

iShares IV Public Limited Company - iShares Healthcare Innovation UCITS ETF Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Weak fundamentals or lack of information.

0 Risks
0 Rewards

About HEAL

Founded
2016
Employees
n/a
CEO
n/a
WebsiteView website
www.ishares.com/uk/institutional/en/products/284216/HEAL

iShares IV Public Limited Company - iShares Healthcare Innovation UCITS ETF is an exchange traded fund launched by BlackRock Asset Management Ireland Limited. The fund is managed by BlackRock Advisors (UK) Limited. It invests in public equity markets across the globe. The fund invests in stocks of companies operating in the healthcare innovation sector. It invests in stocks of small-cap, mid-cap and large-cap companies. The fund seeks to track the performance of the iSTOXX FactSet Breakthrough Healthcare Index, by employing representative sampling methodology. iShares IV Public Limited Company - iShares Healthcare Innovation UCITS ETF was formed on September 8, 2016 and is domiciled in Ireland.

Market Insight

Why today’s lofty prices test investors, and how to stay invested without losing your edge.
Continue reading

U.K. Market Performance

  • 7 Days: 0.3%
  • 3 Months: 4.2%
  • 1 Year: 10.6%
  • Year to Date: 11.3%
The market has stayed flat over the 7 days. As for the longer term, the market has risen 11% in the past 12 months. Looking forward, earnings are forecast to grow by 14% annually. Market details ›